06/01/2018 13:00:00

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Philip Morris International Inc. and Certain Officers – PM

Related content
22 Feb - 
Detailed Research: Economic Perspectives on Herc, Delti..
15 Feb - 
PM INVESTOR ALERT: The Law Offices of Vincent Wong Remi..
14 Feb - 
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Sharehold..
Related debate
20 Apr - 
Jamen det er jo det, Tommy. I USA går det hurtigt, men ..
20 Apr - 
@Delfin Jeg tror, at der er ved at ske et hurtigt holdn..
20 Apr - 
Hvis du var Marlboro, turde du så blive slået i hartkor..

NEW YORK, Jan. 06, 2018 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Philip Morris International Inc. (“Philip Morris” or the “Company”) (NYSE:PM) and certain of its officers.   The class action, filed in United States District Court, for the District of New Jersey, is on behalf of a class consisting of investors who purchased or otherwise acquired Philip Morris securities, seeking to recover compensable damages caused by defendants’ violations of the Securities Exchange Act of 1934.

If you are a shareholder who purchased Philip Morris securities between July 26, 2016, and December 20, 2017, both dates inclusive, you have until February 20, 2018 to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com.  To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased. 

[Click here to join this class action]

Philip Morris is a Virginia corporation with its principal executive offices located at 120 Park Avenue, New York, New York. Philip Morris, through its subsidiaries, manufactures and sells cigarettes, other tobacco products, and other nicotine containing products.

Philip Morris is currently developing a portfolio of Reduced-Risk Products ("RRP"). RRP does not burn tobacco and produces significantly lower levels of harmful or potentially harmful compounds than found in smoke.  Phillip Morris has four RRP platforms in various stages of development and commercialization readiness.  Platform 1 uses a precisely controlled heating device that Philip Morris is commercializing under the IQOS brand name, into which a specially designed and proprietary consumable tobacco product (“IQOS Consumables”) is inserted and heated to generate an aerosol.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) there were irregularities in the clinical experiments that underpin Philip Morris' application to the U.S. Food and Drug Administration (“FDA”) for approval of its iQOS smoking device; and (2) as a result, defendants' statements about Philip Morris' business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

On December 20, 2017, Reuters published a report stating that “[f]ormer employees and contractors [of Phillip Morris] have detailed irregularities in the clinical experiments that underpin Philip Morris International’s application to the FDA for approval of its iQOS smoking device.”

On this news, shares of Philip Morris fell $3.75 per share or approximately 3.5% from its previous closing price to close at $104.37 per share on December 20, 2017, damaging investors. 

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT:

Robert S. Willoughby

Pomerantz LLP

rswilloughby@pomlaw.com

 

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
20 Apr
PM
Jamen det er jo det, Tommy. I USA går det hurtigt, men i Holland er der måske snarere en modreaktion..
1
20 Apr
PM
Hvis du var Marlboro, turde du så blive slået i hartkorn med canabis? Måske om 10 - 20 år, men jeg t..
1
20 Apr
PM
Jo, det har du isoleret set ret i. Min tese er blot den, at Big Tobacco i forvejen har nogle enorme ..
1
19 Apr
PM
@LCB84 Alkohol er langt mere sundhedsskadeligt end rygning, fordi det i flere tilfaelde er involvere..
1
19 Apr
PM
"Philip Morris Plunges the Most in a Decade on Slump in Cigarettes" https://www.bloomberg.com/news/a..
1

Regulatory news

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
GENFIT : Positive Outcome from the 24-month Pre-Planned Safety Review by the DSMB, in RESOLVE-IT Phase 3 Clinical Trial with Elafibranor
2
Lantronix to Participate in Ingram Micro Cloud Summit
3
VINCI : VINCI starts construction works of the Origine building complex in Nanterre, in the western suburbs of Paris
4
Facebook Sued in Class Action That Alleges Users’ Personal Information Was Misused In An Attempt To Influence The 2016 Presidential Election
5
Axiom Real-Time Metrics Exhibiting Fusion eClinical Suite at Clinical Operations in Oncology Trials West

Related stock quotes

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
24 April 2018 06:04:22
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180423.5 - EUROWEB4 - 2018-04-24 07:04:22 - 2018-04-24 06:04:22 - 1000 - Website: OKAY